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Doctor Robert Dores  
Editor-in-chief, 
General and Comparative Endocrinology 
 
Dear Dr. Dores : 
Please find enclosed a manuscript entitled “ The C-terminal domains of melanocortin-2 receptor 
(MC2R) accessory proteins 1 (MRAP1) influence their localization and ACTH-induced cAMP 
production” by Simon Roy, Sébastien J. Roy, Sandra Pinard, Maria Josep Agulleiro, José Miguel 
Cerdá-Reverter, Jean-Luc Parent and myself for publication in General and Comparative 
Endocrinology.   
 
As indicated in the highlight bullets, when stably expressed in 293/FRT cells or in the B16-G4F-
MC1R-deficient cells, we found that MRAP was localized around the nuclear envelope and 
intracellular endosomes while MRAP exhibited a strong localization at the plasma membrane.  In 
addition, MRAP and MRAP2 both colocalized in intracellular compartments whereas MRAP and 
MRAP2 were poorly colocalized and, finally, MRAP2 and MC2R enhanced the expression of 
MRAP1 isoforms and vice versa. We believe our work to be original, not previously performed, and 
representing an extension of our previous publications (Mol. Endoc, 2007 and 2011) as well as those 
recently published in the field. 
 
I will not hide the fact that this is the third attempt for submission of this work. Each time, reviewers 
find the work interesting, well conducted, with one or two reviewers having constructive comments 
for which we were able to provide quite satisfactory answers. However, in each instance, one 
particular reviewer (probably always the same) had very pernicious comments, and each time our 
answers appeared unsatisfactory to warrant publication. 
 
In this new version, we have carefully read all of the comments received before submitting this 
version.  Whenever possible and to the best of our abilities, we have tried to provide all the necessary 
results to circumvent the criticisms previously raised. 
 
This paper has 10 figures and no supplemental material. 
 
I certify that this manuscript represents new, original data, not submitted elsewhere for publication. 
We hope that our paper will meet the fulfillments for publication in Molecular and Cellular 
Endocrinology.  
 
Since you are yourself a specialist in the field, we would greatly appreciate your evaluation of our 
work and you are probably in the best position to choose the appropriate reviewers. We however 
would like to suggest two names, Akiyoshi Takahashi (from Kitasato University, School of Marine 
Biosciences, Japan) and Helgi Schiöth (Uppsala University, Sweden). We would like to mention that 
some colleagues are working exactly in the same field. We would appreciate if the paper was not 
forwarded for review to Dr Adrian J Clark (London, UK) and Patricia Hinke (Rochester, Hinkle) 
and, in addition, not to José Carlos Garcìa-Borròn (University of Murcia, Spain)  
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Abstract 
 
ACTH binding to the human melanocortin-2 receptor (MC2R) requires the presence of the MC2R 
accessory protein1 isoform, MRAP or MRAP. This study evaluated the role of the isoform-specific C-
terminal domains of MRAP with regard to their cellular localization, topology, interaction with MRAP2 
and cAMP production. When stably expressed in HEK293/FRT cells or in B16-G4F mouse melanoma cells 
(an MSH receptor-deficient cell clone), MRAP and MRAPdCT (truncated MRAP1, N-terminal only) 
localized mainly around the nuclear envelope and within dense intracellular endosomes, while MRAP 
exhibited a strong localization at the plasma membrane, and partially with rapid recycling endosomes. 
MRAP and MRAPdCT both exhibited dual-topology (Ncyto/Cexo and Nexo/Ccyto) at the plasma membrane 
whereas MRAP exhibited only Ncyto/Cexo topology at the plasma membrane while adopting dual-topology 
in intracellular compartments. Both MRAP and MRAP2 colocalized in intracellular compartments, as 
opposed to weak colocalization between MRAP and MRAP2. MRAP2 and MC2R enhanced the 
expression of MRAP1 isoforms and vice versa. Moreover, in both HEK293/FRT and B16-G4F cells, 
ACTH failed to activate MC2R unless MRAP1 was present. MRAP1 expression enhanced MC2R cell-
surface expression as well as concentration-dependent cAMP accumulation. In the presence of human or 
zebrafish MC2R, MRAP induced the highest cAMP accumulation while MRAPdCT induced the lowest. 
Together, the present findings indicate that the C-terminal domains of MRAP dictate their intracellular 
localization in addition to regulating ACTH-induced cAMP production. These preferential localizations 
suggest that MRAP is involved in MC2R targeting to the plasma membrane, while MRAPβ may enhance 
ACTH-MC2R coupling to cAMP production. 
 
 
Keywords: MRAP; MC2R; ACTH; MRAP localization; MRAP expression; cAMP 
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1. Introduction 
 Adrenocorticotropic hormone (ACTH) is the major stimulus of the adrenal cortex, having acute and 
chronic effects on both steroidogenic and trophic action [1-3]. The effects of ACTH are mediated through 
its receptor called melanocortin-2 receptor (MC2R) [4]. As in the case of all known melanocortin receptors, 
MC2R is coupled to cAMP production as its main second messenger [5]. MC2R requires the presence of 
MC2R accessory proteins (MRAPs) for its functional expression [6-8].  MRAP1s are involved in 
trafficking and signaling of MC2R, while MRAP2s appear essentially involved in MC2R trafficking to the 
plasma membrane [9-12]. As recently reviewed [13-15], MRAPs are single-passing membrane proteins 
first identified in adipocytes following differentiation of mouse 3T3-L1 fibroblasts [16]. MRAPs have been 
found to be essential for ACTH signaling since some patients with an intact MC2R, but a mutated MRAP 
gene, exhibit familial glucocorticoid deficiency [6, 17]. To date, two types of MRAPs have been identified, 
namely MRAP (MRAP1) and MRAP2. Humans possess two MRAP1 isoforms (MRAP and MRAP) and 
one MRAP2, whereas zebrafish express only one MRAP1 (zfMRAP1) and two different MRAP2s 
(zfMRAP2a and zfMRAP2b) [10] (for review, see [17-19]. Current knowledge indicates that both human 
MRAP1 isoforms share the same N-terminus and transmembrane domain, while most of their C-terminal 
domains arise from the alternative splicing of MRAP transcripts [6, 13, 17, 18]. Orthologs of MRAP1 have 
a strong amino acid identity in their N-terminal domains while their C-termini are completely species- or 
isoform-specific [10].  
MRAPs have an unusual membrane-spanning topology. MRAP adopts a type II topology in cell-
surface enzyme-linked immunoassays (ELISA), as opposed to MRAPβ which exhibits both Nexo/Ccyto (type 
I) and Ncyto/Cexo (type II) topologies [7], as the mouse MRAP1 [8, 9]. Human MRAP1 isoforms confer 
different functional properties to MC2R [7]. When expressed in the HEK 293/FRT cell line, binding 
capacity of ACTH to MC2R and maximal cAMP response are higher in the presence of MRAP than with 
MRAP. In opposition, ACTH potency is increased with MRAP compared to MRAP [7, 11]. One 
question arising from these observations is the nature of the relationship between the structure of MRAPs 
and their intracellular trafficking and functions. We emitted the hypothesis that the isoform-specific 
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structure of the C-terminal domain is involved in specific intracellular localization and association with 
MC2R, thus dictating its targeting and functional expression. The purpose of the present study was hence to 
investigate the role of the C-terminal domains of MRAP proteins with regard to their cellular localization, 
membrane-spanning topology and function with MC2R. To achieve this goal, we constructed a truncated 
version of MRAP1 named MRAPdCT, which includes only the conserved functional domain between 
human MRAP1 isoforms (amino acids 1 to 68). In addition, in order to verify the role of the C-terminal 
domain, cells were transfected with zfMRAP1, in which the C-terminal domain is completely different in 
terms of sequence from the human MRAP1 isoforms. These constructs were assayed in two cell models, 
namely HEK 293/FRT cells and B16-G4F mouse melanoma cells. As previously published, the MC2R-
expressing HEK 293/FRT or CHO cells represent a useful model for studying ACTH signaling because all 
MRAP protein isoforms can be expressed in these cells [7, 10, 11, 20]. In addition, this model reproduces 
concentration-response curves of ACTH-induced cAMP production similarly to those obtained in primary 
cultures of human and rat adrenocortical cells [21, 22].  On the other hand, the B16-G4F mouse melanoma 
cells are characterized by the absence of functional MSH receptors (melanocortin-1 receptor, MC1R), while 
also binding ACTH [23], therefore providing an ideal cell model for comparison with heterologous 
expression of 293/FRT cells.  
 
 
 
 
  
 5 
 
2. Materials and Methods 
2.1. Materials  
  Human MC2R cDNA was provided by Dr. Roger D. Cone (Vollum Institute, Oregon Health and 
Science University, Portland, Oregon). High glucose DMEM (Dulbecco’s Modified Eagle’s Medium) and 
Hygromycin B were from Wisent (St-Jean-Baptiste, QC, Canada). FBS (Fetal Bovine Serum), GlutaMAX 
and Zeocin were from Invitrogen (Burlington, ON, Canada). Primers, antibiotics, the Flp-In
TM
 system, 
293/FRT cells, Lipofectamine, PLUS reagent and the pcDNA3 vector were from Invitrogen. 
Deoxyribonucleic NTPs were obtained from GE Healthcare (Baie d’Urfé, QC, Canada) and the Expand 
High Fidelity
PLUS
 PCR System polymerase from Roche Applied Sciences (Laval, QC, Canada). 
RNAqueous®-4PCR system and DNase I were from Ambion (Austin, TX, USA) Restriction 
endonucleases, modifying enzymes, Standard Taq Polymerase and Phusion DNA polymerase were 
purchased from New England Biolabs (Ipswich, MA, USA); plasmid DNA purification kits and gel 
extraction kits were from Qiagen Inc (Mississauga, ON, Canada). pEGFP was obtained from Clontech 
Laboratories Inc (Mountain View, CA). ACTH (1-24) was purchased from Organon (Toronto, ON, 
Canada). IBMX (3-isobutyl-1-methylxanthine), cAMP and ATP were from Sigma (Oakville, ON, Canada); 
[
3
H]-adenine (25 Ci/mmol) was from Perkin-Elmer (Boston, MA). The mouse monoclonal anti-Myc 
antibody clone 9E10 was obtained from Dr. Michel Bouvier (Groupe de Recherche Universitaire sur le 
Médicament, Université
 
de Montréal, Montréal, Québec, Canada) and was used in the form of cleared 9E10 
hybridoma culture medium [11]. The anti-6xHis rabbit polyclonal antibody (H15 probe) and the anti-Flag 
rabbit polyclonal antibody were from Santa Cruz (La Jolla, CA, USA). Mouse monoclonal anti-protein 
disulfide isomerase (PDI) and anti-giantin were from Abcam (Cambridge, UK). AlexaFluor-coupled 
secondary antibodies were from Invitrogen. Secondary antibodies coupled to horseradish were from GE 
Healthcare. All other chemicals were of grade A purity.   
 Regarding the expression vectors, Myc-MC2R, tagged-MRAP constructions and 6xHis-MRAPdCT-
Flag have been described previously [7, 11]. Briefly, MRAPdCT was constructed with the Expand High 
Fidelity
PLUS
 PCR System. N- and C-terminal epitope-tags were added to MRAPdCT, 6xHis and Flag 
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respectively. SpeI/Kozak/6xHis-MRAP-Flag/XbaI cDNA sequences were amplified from the native 
pcDNA3/MRAPα template. The PCR products were purified, digested and cloned into pcDNA5/FRT, thus 
yielding MRAPdCT fused at its N- and C-terminus with the 6xHis (MGGSHHHHHH) and Flag 
(NYDDDDKC) epitopes respectively. ZfMC2R and zfMRAP1 constructions were previously described 
[10], as well as the MRAP2-Myc construction [11]. 
2.2. Cell culture, transfection and isogenic cell lines  
 Native 293/FRT cells (HEK293 cell line with single genome-integrated Flp Recombinase Target site 
(FRT)) were maintained in high-glucose DMEM with 7 % FBS, 2 mM GlutaMAX and 100 µg/ml Zeocin. 
The Flp recombinase-mediated homologous recombination system (Flp-In
TM
 System) was used to generate 
293/FRT/gene of interest cell lines stably expressing Myc-MC2R, Myc-zfMC2R, 6xHis-MRAP-Flag, 
6xHis-MRAP-Flag and 6xHis-MRAPdCT-Flag and were maintained with 100 µg/ml Hygromycin B 
according to the manufacturer’s recommendations [7]. B16-G4F cells were cultured in high-glucose 
DMEM with 7 % FBS and 2 mM GlutaMAX. Unless otherwise stated, cells were transfected with 0.5 µg of 
plasmid DNA per 35 mm dish using Lipofectamine and PLUS reagent. To maintain similar transcriptional 
and translational activity when required, transfection of pEGFP was used instead of an empty vector as a 
control. 
2.3. Cyclic AMP measurements  
 Transient transfections were performed 24 h after initial seeding of 4 x 10
5
 cells in 35 mm dishes with 
0.5 µg of plasmid DNA. Intracellular cAMP accumulation was performed as described previously [7]. 
Briefly, cells were loaded with tritiated adenine for 2 h, washed once in Hank’s buffered saline (130 mM 
NaCl, 3.5 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 2.5 mM NaHCO2, 5 mM HEPES, pH 7.4, containing 1 
g/l dextrose and 0.1 % BSA) and subsequently stimulated with ACTH, in the presence of the 
phosphodiesterase inhibitor IBMX (iso-butyl-methyl-xanthine), at 37 °C. At the end of the stimulations, 
cells were lysed in 5 % trichloroacetic acid (TCA), and intracellular cAMP accumulation was determined 
by measuring the conversion of [
3
H]-ATP into [
3
H]-cAMP eluted from Dowex and neutral alumina 
chromatography columns.  
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2.4. Immunofluorescence microscopy  
 Cells were seeded on poly-L-lysine glass coverslips placed in 35 mm dishes. If required, cells were 
transfected the following day with 0.5 µg of pcDNA5/FRT/MRAP2-Myc, pcDNA5/FRT/Myc-MC2R, 
pcDNA5/FRT/Myc-zfMC2R or Rab1-EGFP.  The following day, cells were starved for 30 min with fresh 
DMEM without FBS. After one wash in cold PBS, cells were fixed with MeOH and washed with acetone 
as previously described [11]. Labeling for Myc-tagged proteins and MRAP-Flag were performed as 
described previously [7]. Antibodies used for labeling cellular markers or organelles included: mouse anti-
PDI (1:2000), mouse anti-Giantin (1:500). Primary antibodies were detected with goat anti-mouse or anti-
rabbit secondary antibodies coupled to
 
Alexa-Fluo647 and Alexa-Fluor568 respectively, with DAPI used to 
stain the nuclei. Images were acquired on an Olympus Fluoview 1000 (FV1000) laser-scanning confocal 
microscope (Olympus, Japan) using a U Plan S-Apo 60X (1.35 NA) oil immersion objective. Emission 
from each fluorophore was acquired sequentially to avoid fluorophore bleeding. All images were magnified 
in Photoshop CS3 (Adobe Systems Inc.). The pixel fluorograms were obtained and analyzed according to 
the Pearson’s correlation coefficient [24] by plotting pixel values of each component relative to the 
horizontal and vertical axis respectively. Quadrant markers were placed forming background (lower-left), 
red-only (upper-left), green-only (lower-right) and colocalizing (upper-right) areas. The Pearson’s 
correlation coefficient describes the correlation of the intensity distribution between channels using a scale 
from 0 to 1, with 0 indicating no significant correlation and 1.0 indicating complete correlation [24]. 
2.5. Whole cell ELISA procedures  
 Cell-surface ELISA procedures were carried out as previously described [7]. Briefly, cells were seeded 
into poly-L-Lysine-coated 24-well plates at 10
5
 cells/well and transfected with 0.125 µg DNA/well or as 
indicated and with pEGFP (subtracted background OD). After 24 h, cells were washed with PBS, fixed on 
ice for 15 min with 1.85 % formaldehyde, washed, blocked in 10% horse serum and then incubated with a 
mouse anti-c-Myc mixture (1:666), rabbit anti-Flag (1:200) and/or rabbit anti-6xHis (1:200) antibodies and 
detected with appropriate secondary antibodies coupled to horseradish peroxidase. Total expression levels 
were monitored by fixing and permeabilizing cells with 100% MeOH instead of formaldehyde [11]. The 
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substrate H2O2 (0.003%) and the chromophore O-phenylenediamine (1mg/ml) were used to reveal the 
amount of cell-surface receptors [7]. Total and cell-surface expression levels were normalized to pEGFP 
transfection levels. In the characterization of MRAP topology, the cell-surface topology assay strictly 
determines the epitope (Flag or 6xHis) that lies outside unpermeabilized cells and localized at the plasma 
membrane, and not in other membrane compartments found inside the cells, such as endoplasmic reticulum 
(ER) membranes. Henceforth, the term cell-surface topology is used to describe these sets of experiments 
and their interpretations.  
2.6. Western blot analyses 
For the analyses of MRAP proteins, cells were grown in 35 mm dishes, transfected with 0.5 µg of 
plasmid at mid-confluency and lysed at confluency in lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 
1 mM Na2EDTA, 1 mM EGTA, 1 % Triton X-100, 2.5 mM Na pyrophosphate, 1 mM β-glycerophosphate, 
1 mM Na3VO4, 1 µg/ml leupeptin). Samples were processed as described previously [Roy, 2007 #22; Roy, 
2010 #21. Proteins transferred onto nitrocellulose membranes were blocked in TBS-Tween 0.05 % 
(containing 5 % non-fat powdered milk) for at least 30 min, and then incubated with mouse monoclonal 
anti-c-Myc antibody (1:500), with polyclonal rabbit anti-6xHis (1:1000) or anti-Flag (1:1000) for 1 h. After 
washing, appropriate secondary antibodies coupled to horseradish peroxidase (HRP) were incubated for 1 h 
at room temperature and then washed 5 times before detection with enhanced chemiluminescence, 
according to the manufacturer’s instructions. Quantification of blots was normalized to the total level of 
p42/p44
mapk
, since it was found that the level of actin varies under ACTH stimulation, but not the level of 
total p42/p44
mapk
. Following incubation with primary antibodies, membranes were stripped for 2 h with 
glycine 0.2 M (pH 2.5) at 70 °C, then washed, blocked in 1% gelatin, and further incubated with total 
p42/p44
mapk
 for 16 h (dilution 1:1000). Immunoreactive bands were scanned by laser densitometry and 
expressed in arbitrary units.  
2.7. Immunoprecipitation 
 Immunoprecipitation was performed as described previously [Parent, 2009 #20]. Briefly, native 
293/FRT cells were transiently transfected with empty vector, MRAP-Flag or MRAP-Flag with or 
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without MRAP2-Myc. After 42 h, cells were collected in lysis buffer and the lysates clarified by 
centrifugation for 20 min at 14000 g at 4 °C. After pellet removal, 2 µg of anti-Flag monoclonal antibodies 
were added to the supernatants to immunoprecipitate Flag-tagged proteins. After overnight incubation at 4 
°C with A-agarose, the immunoprecipitated proteins were washed and eluted by the addition of 50 μl of 
sample buffer, followed by a 60-min incubation at room temperature (20°C). Initial lysates and 
immunoprecipitated proteins were resolved by SDS–PAGE on 15 % bis-acrylamide gels and 
immunoblotting was performed on nitrocellulose membranes using rabbit polyclonal anti-Flag (1:1000) or 
anti-Myc (1:1000) antibodies. 
2.8. Data analysis  
 The results are presented as mean ± SEM unless stated otherwise. GraphPad Prism 5.0 (GraphPad 
Software, San Diego, CA) was used to determine the EC50, 95% confidence intervals and maximal effects 
using log scaled ACTH concentrations (concentration-response curves: log agonist vs. response; baseline is 
shared and fixed between 0 and 0.1 % cAMP/ATP; Hill slopes were fixed at a value of 1.0). EC50 values are 
given with 95% confidence intervals as mean [lower limit, higher limit]. For non-linear regression analyses, 
p values were obtained with the extra sum-of-squares F test. Statistical analyses for determining 
significance of other parameters were performed by ANOVA followed by Bonferonni’s post-hoc test.    
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3. Results 
3.1 Subcellular localization of human MRAP1 isoforms  
Human MRAPα and MRAPβ isoforms do not share more than 3 single amino acids in their spliced C-
terminal domains, suggesting isoform- and species-specific functions for this portion of the molecule. Thus, 
the equivalent of the human N-terminal conserved domain - (MRAP1 amino acids 1-68, called MRAPdCT) 
- was specifically engineered with an N-terminal 6xHis and a C-terminal Flag-tag in order to delineate the 
role of the C-terminal domain in MRAP and MC2R functions. 
The respective localizations of MRAP, MRAP and MRAPdCT in cells stably expressing these 
proteins individually (in the absence of MC2R) were investigated by confocal microscopy using C-
terminally Flag-tagged MRAPs. MRAP was preferentially localized in intracellular structures and around 
the nuclear envelope (Fig. 1A, left panel, a, b, c), while MRAP exhibited a strong localization at the 
plasma membrane, even under basal conditions (Fig. 1B, left panel, a, b, c). Inside the cell, as shown in the 
merged images and in the fluorograms, MRAP exhibited a good level of colocalization with protein 
disulfide isomerase (PDI), a marker of the ER and with the GTPase Rab1 (a marker for the endosomal 
transport between Golgi and ER), but very weak colocalization with giantin, a cisternae component of the 
Golgi apparatus (Fig. 1Aa, b, c). In contrast, MRAP exhibited only weak or no colocalization with PDI, 
giantin or Rab1 (Fig. 1Ba, b, c). Finally, the truncated MRAP1, MRAPdCT, was concentrated in regions 
neighboring the ER, Golgi and in perinuclear regions (Fig. 1Ca, b, c). In B16-G4F cells, only MRAP and 
MRAPdCT colocalized with Rab1 (Fig. 2).  
 The possibility that MRAP1s are also localized in trafficking endosomes was investigated through 
labeling of endosome markers such as recycling (Rab4), endocytic (Rab5), late (Rab7) and perinuclear 
endosomes (Rab11) [25, 26]. As shown in the merged images and in fluorograms, a fraction of MRAP 
was colocalized with Rab11 and a small fraction with Rab7, but there was no colocalization with Rab 4 or 
Rab5 (Fig. 3A). On the other hand, a small fraction of MRAP was found to colocalize with Rab4, Rab5 
and Rab11, but not with Rab7 (Fig. 3B).  
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3.2. Translocation of MRAP1 isoforms to the plasma membrane by MC2Rs 
The ability of MRAP1s to influence MC2R targeting at the plasma membrane was examined by 
transient transfection of human or zebrafish MC2Rs in stable MRAP1 cell lines. Immunofluorescence 
experiments revealed that the human MC2R (Myc-hMC2R) in cells stably expressing MRAP (Fig. 4A) or 
MRAPβ (Fig. 4B) caused a significant relocalization of MRAP from its intracellular localization (Fig. 1)  
to the plasma membrane where it colocalized with MC2R (Fig. 4A, arrows). In these cells the level of 
expression of MRAP was increased comparatively to untransfected cells (Fig. 4A upper panel; double-
arrow pointing at the upper cell not expressing MC2R). Similar translocation from cytoplasm to plasma 
membrane was also observed using zebrafish MC2R (Myc-zfMC2R) instead of hMC2R (Fig. 4A, lower 
panel). Transfection of the cells with human and zfMC2R also induced a complete translocation of MRAP 
from endosomes to the plasma membrane (Fig. 4B). In the case of Myc-zfMC2R however, a large 
proportion of the receptor remained intracellular (Fig. 4B, lower panel). Interestingly and in contrast with 
results shown in Fig. 1C, in the presence of human MC2R, MRAPdCT was now expressed at the plasma 
membrane (Fig. 4C).  
 Western blotting measurements were performed to validate the immunofluorescence results in which 
MC2R expression was able to increase MRAP expression. All the bands for MRAP were discernible in at 
least five forms (20, 24, 30, 42 and 55 kDa), MRAP in at least two forms (18 and 23 kDa) and MRAPdCT 
in only one form (10 kDa). MRAP and MRAPdCT expressions were largely increased by MC2R 
coexpression (– versus + lanes) as compared to a loading control (total p44/p42mapk) (Fig. 5A).  
 Whole cell-based ELISA experiments were also performed to measure cell-surface and total levels of 
human MC2R in 293/FRT/Myc-MC2R cells (Fig. 5B) and in Myc-zfMC2R (Fig. 5C) transiently 
expressing the different MRAP1s. As shown in Fig. 5B and C, although the coexpression of different 
MRAP1s increased both hMC2R cell-surface expression and total expression to various degrees, the 
increase was higher for cell-surface compared to total expression, and, as previously reported [7, 11], with 
MRAP having a greater effect than MRAP. MRAPdCT increased MC2R cell-surface expression to 
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approximately the same extent as that observed with MRAPα while zfMRAP1 was slightly higher than 
MRAP.  
3.3 Role of MRAP2 in MRAP1 localization  
 The ability of MRAP2 to influence human MRAP1 isoform localization was examined in transient 
MRAP2-Myc-transfected cells stably expressing MRAP-Flag or MRAP-Flag. In non-transfected cells, 
MRAP was localized as described in Fig. 1 and 3; however, as evidenced in merged images, in MRAP2-
transfected cells, MRAP and MRAP2 colocalized in intracellular compartments (Fig. 6A; arrows in upper 
panels). In contrast, MRAP exhibited only a low level of colocalization with MRAP2 (Fig. 6A, lower 
panels and fluorogram). A similar tendency for some colocalization between MRAP-Flag and MRAP2 in 
intracellular compartments, but not between MRAP-Flag and MRAP2, was observed in B16-G4F cells 
(Fig. 6B). 
 The interaction between MRAP2-Myc and Flag-tagged MRAP1 isoforms was confirmed by 
immunoprecipitating the Flag-tagged MRAP1 isoforms. Myc-MRAP2 co-immunoprecipitated with 
MRAP-Flag (Fig. 7A, IP lane 4) as described previously [27] and to a lesser extent with MRAP-Flag 
(Fig. 7B, IP lane 4). When compared to a loading control present in cell lysates (total p44/p42
mapk
) (lower 
panels in Fig.7B and C), MRAP2 expression was increased by nearly 2-fold when MRAP or MRAP was 
present (Fig. 7C). Conversely, MRAP and MRAP expressions were also increased by 2-fold when 
MRAP2 was coexpressed (Fig. 7D). 
3.4 Membrane-spanning topology of MRAPα, MRAPβ and MRAPdCT  
 Measurements of cell-surface expression levels of double-tagged MRAP constructs (6xHis in N-
terminus and Flag in C-terminus) were carried out using the non-permeabilized cell-surface ELISA method. 
MRAPα exhibited a single plasma membrane topology since only the C-terminal Flag tag could be detected 
outside unpermeabilized cells while double detection with both anti-6xHis and anti-Flag antibodies did not 
yield any increase in signal detection. In contrast, both N- and the C-terminus of MRAP and of 
MRAPdCT were detected outside the cells and an increase in double detection could be observed with anti-
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6xHis and anti-Flag antibodies conjointly, indicating that they were inserted into the plasma membrane in 
both orientations (Fig. 7C). Nevertheless, the levels of MRAPdCT at the plasma membrane were relatively 
low as compared to full length MRAP isoforms (N-terminus: MRAP > MRAPdCT > MRAP; C-
terminus: MRAPα  MRAPβ > MRAPdCT). 
3.5.  Influence of MRAP C-terminal domains on MC2R function  
To verify the functional impact of different MRAP C-terminal domains on MC2R function, ACTH-
induced cAMP production was compared in cells stably expressing human MC2R (293/FRT/Myc-MC2R) 
and transiently transfected with MRAPα, MRAPβ, MRAPdCT or zfMRAP1. As previously described [6-8, 
11, 28], despite the endogenous presence of MRAP2 in 293/FRT cells [10, 11], ACTH does not activate 
MC2R unless a MRAP1 is present (data not shown). ACTH induced a dose-dependent increase in cAMP 
with EC50 values of 126 [87-182] pM in MRAPα- and of 338 [286-400] pM in MRAPβ-transfected cells 
(Fig. 8A). With MRAPdCT, cAMP production was obtained at the same threshold concentration of 30 pM 
ACTH, with an EC50 value of 659 [496-873] pM (p < 0.01 compared to MRAP) and a maximal cAMP 
accumulation (Rmax) between that obtained with MRAP and MRAP isoforms [MRAPα (Rmax = 6.3 ± 0.2 
%), MRAPβ (Rmax = 12.5 ± 0.3 %), MRAPdCT (Rmax = 9.6 ± 0.4 %), n = 3] (p < 0.001 compared to 
MRAP and to MRAP). With zfMRAP1, cAMP production was obtained at the threshold concentration 
of 1 pM ACTH with an EC50 value of 20 [9-42] pM (p < 0.001 compared to MRAP) and maximal ACTH 
responses of 7.1 ± 0.2 %. Thus, ACTH potency was as follows: zfMRAP1 > MRAP > MRAP > 
MRAPdCT and the maximal ACTH responses were MRAPβ  > MRAPdCT  > zfMRAP1 > MRAPα. 
 In cells stably expressing the zfMC2R (293/FRT/Myc-zfMC2R) [10], ACTH was unable to stimulate 
zfMC2R in the absence of zfMRAP1 in 293/FRT cells [10]. However, a linear increase in cAMP 
accumulation was observed in MRAP- and MRAP-transfected cells since a plateau was not yet reached 
with 100 nM ACTH (Fig. 8B). Due to incomplete curves with human MRAP1 isoforms, it was not possible 
to gain further insight on ACTH-induced maximal cAMP responses using zfMC2R and human MRAP1 
isoforms. In contrast, in cells expressing zfMRAP1, ACTH stimulation reached a plateau at the 
concentration of 10 nM, with an EC50 of 373 [324, 429] pM, similar to previously published data [10]. 
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These results indicate that zfMRAP1, as compared to MRAP and MRAP, combined to either human or 
zfMC2R, generated a more sensitive ACTH receptor. From these experiments and from the incomplete 
curves obtained for cell surface expression, it is tempting to speculate that maximal ACTH responses may 
reflect cell-surface expression levels (Rmax: MRAP > MRAP > zfMRAP1). 
 As shown in Fig.9A, our results confirmed that B16-G4F cells do not express mouse MRAP1 mRNA, 
therefore MC2R transfection was unable to produce an increase in cAMP upon 100 nM ACTH or 1 µM 
NDP-MSH (a potent -MSH analogue, ligand for the MSH receptor, MC1R), in conditions where forskolin 
(a direct activator of adenylyl cyclases) induced a 40-fold increase over basal level (Fig. 9B). When 
transiently transfected with MC2R in the presence of MRAP or MRAP, MRAP1 expression enhanced 
MC2R cell-surface expression in these cells (Fig. 10A). Under these MRAP1-transfected conditions, 
ACTH increased cAMP accumulation in a dose-dependent manner (Fig. 10B). EC50 and Rmax values 
obtained with MRAP (120 [22, 644] pM), MRAP (243 [76, 771] pM) and zfMRAP1 (34 [5, 228] pM) 
were in accordance with the respective results obtained in 293/FRT/Myc-MC2R cells (Fig. 8A), except for 
the results for MRAPdCT (238 [94, 600] pM) which were similar to the values observed for MRAP.   
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4.  Discussion 
Using two different cell models which share the lack of MRAP1 and MCR expression, the present study 
demonstrates that the isoform-specific C-terminal domains of MRAP1s have distinct impacts on the 
subcellular localization of MRAP1s and on ACTH-induced cAMP signaling.  Our results show that 
MRAP is preferentially associated with intracellular compartments, while MRAP is primarily associated 
with the plasma membrane. MRAP2 was also found to colocalize with MRAP and increased its 
localization at the plasma membrane, as opposed to low or absence of localization with MRAPβ. We also 
provide evidence that expression of MRAP1 isoforms is increased by both MC2R and MRAP2 
coexpression and vice versa. Finally, our data clearly indicate that the C-terminal segments of MRAP1 
isoforms modulate cAMP responses to ACTH.  
Involvement of MRAP1 C-terminal domains in their respective localizations -  As shown herein, a large 
proportion of MRAP, expressed either alone, with MC2R or with MRAP2, was localized in the 
endoplasmic reticulum and in Rab1 and Rab11-positive endosomes as well as in vicinity of the nuclear 
envelope. In contrast, MRAP was mainly associated with the plasma membrane, but also partially with 
recycling endosomes (Rab4 and Rab5). The observation that only a limited fraction of MC2R 
colocalizes with Rab4 and Rab5 endosomes is in agreement with our recent results that the 
maximal extent of ACTH-induced MC2R internalization is only from 20 to 30 % and that 28% of the 
internalized receptors were recycled back to the plasma membrane [26].On the other hand, the truncated 
MRAP1 version lacking the C-terminal domain (MRAPdCT) was found essentially in the Golgi apparatus 
and in the early secretory Rab1-positive endosomes, indicating that the C-terminal domains of MRAP1 
possess an amino acid motif that is essential for proper sorting from the Golgi apparatus. These findings 
suggest that in the absence of MC2R, MRAP is preferentially sorted to pre-Golgi compartments while 
MRAP is preferentially sorted to post-Golgi compartments. Such localizations point to a possible role  of 
MRAP in the trafficking between the endoplasmic reticulum and Golgi apparatus [25, 29] or may 
alternatively be involved in an interaction with nucleoporin 50, which has been shown to interact with 
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MC2R after prolonged ACTH stimulation [30]. In fact, the role of MRAPs in absence of MC2R remains 
unknown but could likely be differently involved in protein transport unrelated to ACTH signaling, as 
described initially in adipocytes [31]. Furthermore and importantly, our results show that MRAP1 not only 
increases MC2R expression, as previously described [8, 11], but that both human and zfMC2R are able to 
modulate the localization of MRAP isoforms and to promote ACTH signaling, thus indicating that MRAP1 
isoform expressions are increased by both MC2R and MRAP2 coexpression.  
We found that MRAP2 colocalized massively with MRAP and increased its localization at the plasma 
membrane. Accordingly, and as recently observed [27], MRAP2 and MRAP, as well as MRAP2 and 
MRAP, were found within the same protein complex following immunoprecipitation. These observations 
are thus is in agreement with other studies indicating that the conserved N-terminal domain is probably 
sufficient for this interaction [13, 27].  The present results are also in agreement with studies performed in 
zebrafish, where the coexpression of zfMRAP2a and zfMRAP2b enhanced the effects of zfMRAP1 on 
zfMC2R signaling [10]. In addition, MRAP1 isoform expression was increased by both MC2R and 
MRAP2 coexpression, suggesting that MRAP2 may regulate the expression or functionality of various 
MRAP1s according to the different C-terminal domains of the MRAP1s. However, why or how exactly 
MRAP2 promotes MRAP targeting to the plasma membrane remains to be explored in greater detail (for 
review see [17]), but may be related to physiological events independent from ACTH signaling, such as in 
protection against cell toxicity [32]. We also found that, at the plasma membrane, MRAP appeared in the 
type II (Ncyto/Cexo) orientation, while MRAP and MRAPdCT both exhibited dual-topology (Ncyto/Cexo and 
Nexo/Ccyto). As recently reviewed  [13-15], the roles that may be associated with dual-topology of MRAPs 
proteins remain to be explored and may include interaction with signaling molecules, docking-associated 
events, molecular chaperoning mechanism, or structural organization, similarly to what is observed during 
aquaporin-1 topogenesis [33-35]. 
Role of MRAP1 C-terminal domains on functional MC2R expression - Our data also clearly indicate that 
the C-terminal segments of MRAP1 isoforms modulate cAMP responses to ACTH. Results herein 
demonstrate that the truncated MRAPdCT is sufficient to drive functional expression of MC2R. However, 
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MRAPdCT coexpression with MC2R caused intermediate maximal cAMP responses and lower ACTH 
potency (decreased sensitivity for cAMP production) indicating that the C-termini of human MRAP1 
isoforms are involved in signaling events by increasing ACTH potency for MC2R. This may occur by 
modifying the affinity of MC2R for ACTH [7]. In turn, ACTH potency may be MRAP1 isoform-dependent 
and species-specific since the C-terminal domains of zfMRAP1, mouse and human MRAP1s are drastically 
different. Indeed, zfMRAP1 protein has a major enhancing effect on ACTH potency. On the other hand, 
maximal responses obtained using the different MRAP1s are correlated with the cell surface expression of 
MC2R. Thus, the C-terminal domain confers differential capacity (maximal response) and sensitivity to the 
receptor. In addition, because the C-teminal domain of the zfMRAP1 is completely different in terms of 
sequence from human MRAP1 isoforms, the results of the zMRAP1 experiments performed herein fully 
support and corroborate data obtained with the human MRAP1 isoforms.  
 In summary, our results indicate that MRAP as well as MRAPdCT are preferentially localized within 
intracellular compartments associated with early events of the secretory pathway (Rab1, Rab11). In 
contrast, MRAP is mainly associated with plasma membrane and recycling endosomes (Rab4 and Rab5). 
These findings suggest that the C-terminal domain of MRAP is responsible for MC2R targeting to the 
plasma membrane while MRAPβ, with its distinctive C-terminal topology, enhances ACTH-MC2R 
coupling to adenylyl cyclase activation and cAMP accumulation, potentially aiding in the rapid 
internalization and recycling of MC2R to the plasma membrane, as recently demonstrated by our group 
[26]. 
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Figure legends  
 
Fig. 1. Influence of the C-terminal domain of MRAP and of MRAP on their localization in HEK293 
cells. Confocal microscopy images of cells stably expressing 6xHis-MRAP-Flag in the absence of human 
MC2R. Cells were labeled for MRAP (A), MRAP (B) or MRAPdCT (C) (all Flag-tagged and with 
specific antibodies against either protein disulfide isomerase (PDI) as a marker of the endoplasmic 
reticulum (ER) (a), giantin, as a marker of Golgi cisternae (b) or labeled by Rab1-EGFP for ER-to-Golgi 
endosomes (c). Colocalization fluorograms based on 3D reconstructions are shown in the right column. The 
x axis of the fluorograms is representative of green labeling and the y axis is representative of red staining. 
Colocalization between green-labeling and red-labeling voxels is shown as being proportional to each other 
in the fluorograms and corresponds to the yellow color in merged slices. Images are representative of three 
independent experiments where at least 50 cells were examined. Scale bars: 10 µm. Arrows point to 
colocalization (yellow pseudo-color). 
 
Fig. 2. Influence of the C-terminal domain of MRAP1s for their localization with Rab1 in B16-G4F cells. 
Confocal microscopy images of B16-G4F cells transiently expressing 6xHis-MRAP-Flag, 6xHis-
MRAP-Flag or 6xHis-MRAPdCT-Flag and Rab1-EGFP in the absence of MC2R. Fixed cells were 
labeled for MRAP1s (Flag tag; red) and Rab1-EGFP (green). Images are representative of two independent 
experiments where at least 30 cells were examined. Scale bars: 10 µm. 
 
Fig. 3. Influence of the C-terminal domain of human MRAP1 isoforms on their trafficking in endosomes. 
Confocal microscopy images of cells stably expressing 6xHis-MRAP-Flag (A) or 6xHis-MRAP-Flag 
(B) in the absence of human MC2R. Cells were labeled for MRAP1s (Flag-tagged and by transient 
transfection of Rab4-, Rab5-, Rab7- or Rab11-EGFP). Images are representative of two independent 
experiments where at least 50 cells were examined. Scale bar: 10 µm (equivalent for all images). Arrows 
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point to colocalization (yellow pseudo-color). Colocalization fluorograms based on 3D reconstructions are 
shown in the right column, as described in Fig. 3. 
 
Fig. 4. Influence of MC2R expression on human MRAP1 localizations and expressions. Confocal 
microscopy images of cells stably expressing 6xHis-MRAP-Flag (A), 6xHis-MRAP-Flag (B) or 6xHis-
MRAPdCT-Flag (C) in the presence of transiently transfected human Myc-MC2R (Myc-hMC2R) or 
zebrafish Myc-MC2R (Myc-zfMC2R) (upper and lower images respectively). Fixed cells were labeled for 
MRAP (Flag-tagged and Myc-tagged receptors. Arrows point at the colocalization between red (MRAP) 
and green (MC2Rs) channels which yield a yellow color in merged images. In one exception, a horizontal 
double arrow points to a cell not expressing human Myc-MC2R in panel A. Images are representative of 
two independent experiments where at least 50 cells were examined. Scale bar: 10 µm.  
 
Fig. 5. Influence of MRAP1 on MC2R expression.  A) Immunoblots of proteins collected from native 
293/FRT cells transiently expressing 6xHis-MRAP-Flag, 6xHis-MRAP-Flag or 6xHis-MRAPdCT-Flag 
with (+) or without (-) MC2R and probed for the Flag-tag (upper panel) or stripped and probed for the 
unphosphorylated forms of p44/p42 (lower panel). M  (molecular mass in kDa) is shown on the right. The 
blots are representative of three independent experiments; nsp, non specific band. B, C) 293/FRT/Myc-
MC2R cells (human MC2R) (B) and 293/FRT/zfMC2R cells (C) were transfected with pEGFP (subtracted 
background OD) and transiently transfected with full-length MRAP1s or the truncated MRAPdCT. Cell-
surface and total Myc-MC2R expression was measured by ELISA as described in Methods. Results 
represent the mean ± SEM of three experiments, each performed in triplicate. *, p < 0.05; **, p <0.01 and 
***, p < 0.001, compared with control or indicated conditions.  
 
Fig. 6. Influence of MRAP2 on human MRAP1 isoform localization in 293/FRT/Myc-MC2R cells (human 
MC2R) (A) and B16-G4F cells (B). Confocal microscopy images acquired from cells stably expressing 
6xHis-MRAP-Flag (upper images) or 6xHis-MRAP-Flag (lower images) transiently expressing 
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MRAP2-Myc. Fixed cells were labeled for MRAP1s (Flag-tagged) and for MRAP2-Myc (Myc-tagged). 
Images are representative of three independent experiments where at least 50 cells were examined. Scale 
bar: 10 µm. Arrows point to colocalization (yellow pseudo-color).   
 
Fig. 7. Western blotting before (lysates) and after immunoprecipitation (IP) of 6xHis-MRAP-Flag (A) or 
6xHis-MRAP-Flag (B) transiently expressed or not with MRAP2-Myc in 293/FRT cells. For Western 
blotting, membranes were incubated with anti-c-Myc antibody, then stripped, washed and further incubated 
with anti-Flag antibody and then with total p42/p44
mapk
 (p44/p42) for quantification, as described in 
Materials and Methods. Molecular mass (M) in kDa is shown on the left. C) Quantification of MRAP2 and 
p44/p42
mapk
 expression in cell lysates with and without MRAP1 isoform expression. D) Quantification of 
MRAP, MRAP and p44/p42mapk expression in cell lysates with and without MRAP2 expression. Results 
represent the mean ± SEM of three experiments, each performed in triplicate. E) Membrane-spanning 
topology of human MRAP1 isoforms. Cell-surface ELISA performed on fixed and unpermeabilized 
293/FRT cells transiently expressing a GFP (CTL), 6xHis-MRAP-Flag, 6xHis-MRAP-Flag or 6xHis-
MRAPdCT-Flag. In different sets of wells, epitope tags exposed outside the cells were detected with rabbit 
anti-Flag or anti-6xHis antibodies or with both antibodies to allow the detection of either N-terminal or C-
terminal tags or both simultaneously. Primary antibodies were detected with the same secondary antibodies 
linked to HRP. Statistical significance: *: p < 0.05, **: p < 0.01 and *** p < 0.001. Results represent the 
mean ± SEM of four experiments, each performed in triplicate.  
 
Fig. 8. Influence of MRAP1 C-terminal domains on ACTH-induced cAMP accumulation.  293/FRT/Myc-
MC2R cells (human MC2R, hMC2R) (A) or 293/FRT/Myc-zfMC2R cells (zebrafish MC2R, zfMC2R) (B) 
transiently expressing full-length MRAP1s or the truncated MRAPdCT were incubated with increasing 
ACTH concentrations in order to measure cAMP accumulation, as described in Methods. Results represent 
the mean ± SEM of three experiments, each performed in triplicate. 
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Fig. 9. B16-G4F cells do not express mouse MRAP1 and transfected MC2R is non-functional in these cells. 
A) Reversed-transcribed total RNA from M3 and B16-G4F cells was subjected to PCR against mouse 
MRAP1 (125 bp). B) B16-G4F cells transfected with an empty vector (pcDNA3) or with Myc-MC2R 
(pcDNA3/Myc-MC2R) were challenged for 15 min with vehicle, 100 nM ACTH, 1 µM NDP-MSH (a 
potent -MSH analogue, ligand for the MSH receptor, MC1R) or 1 µM FSK (forskolin) (a direct activator 
of adenylyl cyclases)  in the presence of 1 mM IBMX (phosphodiesterase inhibitor). Results are the mean ± 
SE of two independent experiments.   
 
Fig. 10.  Localization of MC2R and MRAP1 isoforms in B16-G4F cells (A) and influence of MRAP1 C-
terminal domains on MC2R function in B16-G4F cells (B). A) Confocal microscopy images acquired from 
cells transiently expressing Myc-MC2R alone (left images) or coexpressing MRAP-Flag (middle images) 
or MRAP-Flag (right images). Fixed and permeabilized cells were labeled for MRAP1s (Flag tag; red 
pseudocolor) and for Myc-MC2R (Myc tag; green pseudocolor) and counterstained with DAPI (nuclei; blue 
pseudocolor). Images are representative of two independent experiments where at least 50 cells were 
examined. Arrow indicates membrane localization of MC2R. Scale bar: 10 µm. B) ACTH-induced 
concentration-response curves performed on B16-G4F cells transiently expressing human MC2R and 
MRAP, MRAP, MRAPdCT or zfMRAP1. The inset shows the normalized curves from 0 to 100% of 
each curve in order to better illustrate the changes in EC50 values (n = 3). B: basal. 
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